{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "MYOD1",
                "DNA Alteration": "c.365T>G",
                "GeneMutation": "p.L122R Spliceregionvariant-LOF",
                "VariantAlleleFraction": "7.83%"
            },
            {
                "Gene": "PDGFRB",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.T681I Spliceregionvariant-GOF",
                "VariantAlleleFraction": "16.05%"
            },
            {
                "Gene": "ARID2",
                "DNA Alteration": " c.798G>A",
                "GeneMutation": " p.W266* Spliceregionvariant-LOF",
                "VariantAlleleFraction": "6.51%"
            },
            {
                "Gene": "MSH2",
                "DNA Alteration": "c.1906G>C",
                "GeneMutation": "p.A636P Nonsense-GOF",
                "VariantAlleleFraction": "5.65%"
            },
            {
                "Gene": "TP53",
                "DNA Alteration": "c.523C>T",
                "GeneMutation": "p.R213L Frameshift-LOF",
                "VariantAlleleFraction": "9.0%"
            },
            {
                "Gene": "KIT",
                "DNA Alteration": "c.1676T>A",
                "GeneMutation": "p.Y846C Nonsense-GOF",
                "VariantAlleleFraction": "5.54%"
            },
            {
                "Gene": "NRAS",
                "DNA Alteration": "c.181_182delinsTT",
                "GeneMutation": "p.G13X Frameshift-LOF",
                "VariantAlleleFraction": "5.36%"
            },
            {
                "Gene": "TOP2A",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.G1386D Nonsense-LOF",
                "VariantAlleleFraction": "4.57%"
            },
            {
                "Gene": "FGFR2",
                "DNA Alteration": "c.758C>G",
                "GeneMutation": "p.N549H Stopgain-LOF",
                "VariantAlleleFraction": "1.96%"
            },
            {
                "Gene": "NCSTN",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A572G Spliceregionvariant-LOF",
                "VariantAlleleFraction": "7.42%"
            },
            {
                "Gene": "PIK3CA",
                "DNA Alteration": "c.1633G>A",
                "GeneMutation": "p.H1047Q Spliceregionvariant-LOF",
                "VariantAlleleFraction": "8.87%"
            },
            {
                "Gene": "STAT5B",
                "DNA Alteration": "c.1924A>C",
                "GeneMutation": "p.N713_A714insKGKGGG Stopgain-LOF",
                "VariantAlleleFraction": "9.42%"
            }
        ],
        "Germline": []
    }
}